Bioorganic and Medicinal Chemistry Letters p. 2403 - 2408 (1997)
Update date:2022-09-26
Topics:
Belliotti, Thomas R.
Kesten, Suzanne R.
Rubin, John R.
Wustrow, David J.
Georgic, Lynn M.
Zoski, Kim T.
Akunne, Hyacinth C.
Wise, Lawrence D.
The dopamine D3 receptor is an attractive target for the treatment of schizophrenia. We identified PD137557 (V) as a ligand for the D2 receptor and desired to prepare a selective D3 compound. SAR studies involving different amides and different phenyl piperazines have led to the discovery of 8a and 8c as selective D3 receptor ligands.
View Morewebsite:http://www.dulynet.com/
Contact:025-84699383 -8003
Address:Room 503, Building 2, Chuangxinhui, No. 61 Wenjing Road, High-tech Development Zone, Pukou District, Nanjing City, Jiangsu Province Nanjing, Jiangsu
KAIYUAN CHEMICAL COMPANY LIMITED.
website:http://www.kaiyuanchem.com
Contact:+86-22-59891255/66/77
Address:B-2205, Kuangshi International Building, Yingbin Road, XiangLuo Bay Business District, Binhai New area, Tianjin, China.
Taizhou Huading Chemical Co.,Ltd(expird)
Contact:+86-576-88583898
Address:Economic&Technology development zone,Taizhou City,Zhejiang Province,China
Wuxi D-Stone International Co., Ltd.
Contact:+86-510-82740567
Address:21F Hengtong Int'l Centre, 215Zhongshan Road, Wuxi, Jiangsu,China
Shanghai doly chemical Co.,Ltd
Contact:+86-21-34716221
Address:No.328,WuHe Roard,MinHang,ShangHai China
Doi:10.1002/ejoc.200900407
(2009)Doi:10.14233/ajchem.2013.13227
(2013)Doi:10.1016/j.bmcl.2004.07.001
(2004)Doi:10.1016/S0040-4039(00)94492-7
(1990)Doi:10.1016/S0040-4020(97)10292-7
(1998)Doi:10.1016/S0957-4166(97)00499-0
(1997)
